Kingwood, TX, United States of America

Chin-Yo Lin

This inventor holds 1 USPTO granted patent. Top assignee: University of Houston System. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chin-Yo Lin. Retrieved from https://idiyas.com/inventor/chin-yo-lin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Chin-Yo Lin: Inventor of a Potentially Less-Toxic Cancer Treatment

Introduction

Chin-Yo Lin is an inventor based in Kingwood, Texas, whose patent work explores small-molecule compounds that target liver X receptors (LXRs). His listed patent describes a potential approach to cancer treatment designed to affect tumor cells while limiting activity against dividing non-malignant cells.

Latest Patents

Lin is associated with 1 patent, titled “Small Molecule Liver X Receptor Modulators and Uses Thereof.” The patent describes LXR modulators and derivatives that target metabolic pathways favored by cancer cells and activate a cell-death mechanism distinct from those induced by conventional chemotherapy.

The proposed compounds may offer a less-toxic alternative to chemotherapy or be used alongside it to improve treatment efficacy and reduce the likelihood of resistance. The patent also discusses their potential use as second-line treatments when chemotherapy is ineffective or cancer cells become resistant.

Career Highlights

Lin’s listed work is associated with the University of Houston System. His patent focuses on a therapeutic strategy that seeks to exploit differences between tumor cells and non-malignant cells, with the aim of supporting more selective cancer treatment.

Collaborations

Scott R. Gilbertson is identified as Lin’s coworker. Their association is noted alongside Lin’s patent-related work connected with the University of Houston System.

Conclusion

Chin-Yo Lin’s patent presents liver X receptor modulation as a potential way to target cancer-cell metabolism and complement or provide an alternative to chemotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…